News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Tejas Patil: DeepPT predicts tumor mRNA expression from hematoxylin and eosin slides
Photo of Danh-Tai Hoang taken from www.eurekalert.org
Jul 11, 2024, 14:39

Tejas Patil: DeepPT predicts tumor mRNA expression from hematoxylin and eosin slides

Tejas Patil, Thoracic oncologist at University of Colorado Cancer Center, shared a paper by Danh-Tai Hoang et al. on X: 

“Delighted to have contributed the ALK dataset to this AI study in Nature.

DeepPT predicts tumor mRNA expression from H and E slides and ENLIGHT predicts response to targeted and immune therapies from the inferred expression values.”

Source: Tejas Patil/X

A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics.

Authors: Danh-Tai Hoang, Gal Dinstag, Eldad D. Shulman, Leandro C. Hermida, Doreen S. Ben-Zvi, Efrat Elis, Katherine Caley, Stephen-John Sammut, Sanju Sinha, Neelam Sinha, Christopher H. Dampier, Chani Stossel, Tejas Patil, Arun Rajan, Wiem Lassoued, Julius Strauss, Shania Bailey, Clint Allen, Jason Redman, Tuvik Beker, Peng Jiang, Talia Golan, Scott Wilkinson, Adam G. Sowalsky, Sharon R. Pine, Carlos Caldas, James L. Gulley, Kenneth Aldape, Ranit Aharonov, Eric A. Stone and Eytan Ruppin.

Tejas Patil

Adam G. Sowalsky AI ALK Arun Rajan cancer Carlos Caldas Chani Stossel Christopher H. Dampier Clint Allen Danh-Tai Hoang DeepPT Doreen S. Ben-Zvi Efrat Elis Eldad D. Shulman Eric A. Stone Eytan Ruppin Gal Dinstag immune therapies James L. Gulley Jason Redman Julius Strauss Katherine Caley Kenneth Aldape Leandro C. Hermida mRNA Nature Neelam Sinha OncoDaily Oncology Peng Jiang Ranit Aharonov Sanju Sinha Scott Wilkinson Shania Bailey Sharon R. Pine Stephen John Sammut Talia Golan Tejas Patil Tuvik Beker University of Colorado Cancer Center Wiem Lassoued
Special Coverage
Blog
Dec 21, 2024, 19:42
Ruben Mesa: Over 200 research staff of Atrium Health Wake Forest Baptist trained on Just Ask Increasing Diversity in Cancer Clinical Trials
Blog
Dec 21, 2024, 19:39
Kyaw Thein: Investigational Treatments for Thyroid and Head and Neck Cancers
Blog
Dec 21, 2024, 19:25
Hesham ElGhazaly: From an academic institution into a globally recognized hub for healthcare, research and innovation
Blog
Dec 21, 2024, 19:21
Douglas Flora: The 19 Words I’m Learning to Embrace as a Leader in 2025
Blog
Dec 21, 2024, 19:19
Registration and abstract submission open for the PTCOG63 - SIOP Europe
Blog
Dec 21, 2024, 19:18
The Institute of Cancer Research's annual report for 2023-2024
Blog
Dec 21, 2024, 19:14
Pembrolizumab plus chemotherapy with or without bevacizumab for metastatic cervical cancer
Blog
Dec 21, 2024, 19:12
The International Cancer Control Partnership's latest global review of NCCPs is out now - NCI Center for Global Health
Blog
Dec 21, 2024, 18:59
Nominations for the SIOP Europe Lifetime Achievement are open
Blog
Dec 21, 2024, 18:57
Petra Ibum Adjah: Get your last self breast exams before the festivities begin
Blog
Dec 21, 2024, 18:54
Introducing Innovation at Your Fingertips - Total Health | Oncology
Insight
Dec 21, 2024, 18:46
Marengo Initiated Phase 2 Trial of Invikafusp Alfa for PD-1 Resistant Tumors, Expands to Europe